LiveWell Announces Stock Option Grants
OTTAWA, ONTARIO, March 11, 2019, – LiveWell Canada Inc. (“LiveWell” or the “Company“), (CSE: LVWL),
today announced that it has granted an aggregate of 9,350,000 options to purchase common stock to
certain officers, employees and consultants. The options are exercisable at a price of $0.74 per
share and will vest one third on each December 31st starting with December 31, 2019. These
options will expire in five years. All options were granted in accordance with LiveWell’s stock
option plan as approved by the shareholders in December 2018.
LiveWell is an innovative Canadian health and wellness company focused on the advanced research of
CBD and other cannabinoids. Utilizing state-of-the-art manufacturing facilities, LiveWell aims to
cost-effectively extract and refine large quantities of hemp-derived CBD, better enabling it to
develop, market and distribute wholesale and consumer products.
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts
responsibility for the adequacy or accuracy of this release.
SOURCE LiveWell Canada Inc.
For more information, visit livewellcorp.com
English – Deborah Stokes, 819 576-3789 – [email protected]
French – Conrad Seguin – [email protected]
Conrad Seguin, 437-226-7002 – [email protected]
David Rendimonti, President and CEO Steven Archambault, CFO and CAO